Thyroid cancer recurrence risk was not elevated among patients with high-normal vs low-normal exposure to TSH following thyroidectomy.

A 5-year follow-up of those randomized to receive or not receive radioiodine after thyroidectomy showed nearly the same low ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis, risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in epithelial ...

Medullary thyroid cancer (MTC) is a rare yet aggressive form of thyroid cancer, accounting for 5–10% of all thyroid malignancies but disproportionately ...

Recent observational studies have inconsistently reported associations of GLP-1 use with both medullary thyroid cancer and differentiated thyroid cancer, but these studies have been subject to bias.

MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest ...

gastric cancer and bile duct cancer, advanced or metastatic differentiated thyroid cancer, metastatic urothelial carcinoma of the bladder cancer, urethral cancer, ureter cancer, renal pelvis cancer, ...

A phase 2 trial found that dual immune checkpoint inhibition with nivolumab and ipilimumab shows promise in anaplastic thyroid cancer, but limited effectiveness in radioiodine refractory ...